Why did Tesla face a new self-driving probe?
How will the US government shutdown impact markets?
What caused Nvidia stock to surge recently?
Why is China tightening rare earth export controls?
How did Israel-Hamas ceasefire affect oil prices?
What’s behind Goldman Sachs’ strategic confidence?
Why is JPMorgan requiring biometric data for staff?
Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
investors.com/news/technology/apogee-therapeutics-stock-eczema-treatment-dupixent-offering
Shares of Apogee Therapeutics have gained 34% over the past two days as the small biotech looks to take on Regeneron and Sanofi.
The post Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-10-09 17:03:49.